Case Report on Septal Ablation for Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy
Author Information
Author(s): Tengiz Istemihan, Ercan Ertugrul, Alioglu Emin, Turk Ugur O
Primary Institution: Central Hospital, Cardiology Department, Izmir, Turkey
Hypothesis
Can percutaneous septal ablation effectively treat mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHC)?
Conclusion
Percutaneous septal ablation is a successful and less invasive alternative to surgery for patients with MVOHC.
Supporting Evidence
- The patient had significant improvement in symptoms and functional capacity after the procedure.
- Echocardiographic examinations showed reduced left atrial dimension and interventricular septum thickness post-procedure.
- The patient was asymptomatic at 6 months' follow-up.
Takeaway
This study shows that a special heart procedure can help a man with a rare heart problem feel better and breathe easier.
Methodology
The patient underwent percutaneous septal ablation using alcohol injection to reduce the pressure gradient in the heart.
Limitations
The study is based on a single case, which limits the generalizability of the findings.
Participant Demographics
A 34-year-old man with a history of hypertrophic cardiomyopathy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website